NCT01949896 2013.

Methods	Single‐centre, randomised, controlled trial in USA
Participants	Inclusion criteria: infants born at < 31 weeks' gestational age; 3 to 7 days old at time of consent Exclusion criteria: infant with multiple congenital anomalies; infant with suspected/confirmed genetic anomalies; infant with suspected/confirmed congenital immune deficiencies
Interventions	Total N = 12 Group 1: NPO approximately 4 hours before receiving a blood transfusion and NPO until approximately 24 hours after the blood transfusion Group 2: continued feeding during the transfusion (at the discretion of the medical team)
Outcomes	Primary outcome: pro‐inflammatory cytokine response Secondary outcomes: none specified
Notes	Study terminated due to insufficient patient population for enrolment. No results reported; unclear if available